Login | Register
 
   
 Ongoing studies
  

CAMEO Discoveries

DESCRIPTIVE RESEARCH:

How common is psychosis? We found, from 2002 to 2007, 285 cases of psychosis in South Cambs. This is as much as you would expect from an urban setting even though we are quite a rural setting. So if you look for it, you find more than you would have thought. 

Recreational Drugs: Substance use is more common in our patients than the general population. About twice as common. 

Cognition. Many people with psychosis have memory and problem solving difficulties. There is little difference between diagnoses here (eg schizophrenia and bipolar score similarly). There is a lot of variability, and those patients with worse memories tend to be more disabled.

Back to the top 

BIOLOGY RESEARCH:

Brain and Mind: Its never been clear why dopamine problems should lead to psychosis. We have shown that it is likely to be problems with dopamine’s normal role in learning about important events that, when it goes wrong, leads to psychotic symptoms. We showed that by getting people to learn about important events in the MRI scanner, and we showed that brain dopamine regions were different in patients and controls. 

Genetics and inheritance. Emmy and Belinda have shown that certain features of psychosis are present even in unaffected relatives. The most heritable problem seems to be motor dysfunction, which could reflect a problem in brain development, even in relatives. Peter and Linda have found a blood test that is better than chance at saying whether you have a psychosis, a relative with psychosis or no psychosis. 

Immune system: Some cases of psychosis may have a clear biological causation – such as antibodies to receptors for the neurotransmitter glutamate. Maybe these cases can be treated with immunosuppressant treatments not antipsychotics.

Back to the top 

TREATMENT RESEARCH 

Social cognition: Modafinil improves recognition of emotions (Linda, Peter) 

Social recovery: CBT helps people with schizophrenia get back to work (David Fowler, Michelle, Carolyn, Dorothy…)

 

  

Research

Research and Service Evaluation at CAMEO

CAMEO is committed to providing the best service possible. This means that we take research and service evaluation seriously, contributing to and implementing the best practice from around the world. 

Service users, their families and carers come first in the CAMEO team.  Everyone in CAMEO shares a strong commitment to assess individuals’ difficulties, needs and strengths in order to deliver the most effective interventions on terms that suits our service users and their family.

As part of this, service users, families and staff are all active in research and service evaluations.   We believe that all our service users should have the opportunity to take part in research, if they wish.  This means that the results of our studies are relevant to our service users.

We have several types of research projects running in CAMEO at any one time.  This includes studies of new psychological therapies, new medications, studies of what may be going wrong in early psychosis and why.  You may be invited to take part in some of these studies.

Your clinical care will always come first and will not be affected if you decide to take part in research.  All our projects are ethically approved and we make sure that people are not asked to take part in many research projects.

Any information that we collect about our service users and their families remains strictly confidential in line with the Data Protection Act.  Person Identifiable Information is never used in research, hence your details will always remain strictly anonymous.

We believe that this is an important part of our work and value our association with the University of Cambridge (http://www.psychiatry.cam.ac.uk/) and collaborating Universities, with which we are in partnership, to make sure that CAMEO gives the best possible service.  The team will always make it clear when you are being asked to take part in any research.  Your participation and consent would be most valued and help further improve the service we offer.

Back to Top 
 Some CAMEO Publications
 
  
 Some previous studies
  

 
CAMEO Questions

Why do research?

Because we think it’s important to understand more about psychosis. We think that learning more about this condition is important to people with psychosis and their families. Better understanding will also help in designing treatments and health services. It’s not clear why, but services that take part in health research achieve better outcomes than those that don’t. 

What kinds of research do we do in CAMEO?

DESCRIPTIVE RESEARCH:

How common is psychosis? We are especially unclear about how common mild psychosis is. Can we develop ways of predicting how common psychosis will be, for any given area, from simple statistics like the number of people living in an area and how old they are? This would help NHS planners knowing how many staff to employ in different parts of the country; it also suggests causes and mechanisms behind the development of psychosis. 

For people with psychosis, how many have jobs? How many have other health problems, such as being in poor physical health? How many use drugs and alcohol? How many are well enough to live on their own, and how many need supported accommodation? This will help NHS planning to deliver the right treatments. 

Do people with psychosis have memory and problem solving difficulties? Do these difficulties       explain in part why some patients find it hard to get or keep jobs? 

Back to the top 

BIOLOGY RESEARCH:

Are there particular brain areas or brain processes that are affected in psychosis? Is there a clear relationship between symptoms and brain function or not? Currently we are looking, using MRI brain scanning, especially at 2 kinds of symptoms – positive symptoms (unusual ideas and hallucinations) and negative symptoms (especially difficulties with motivation and enjoyment). Do different brain problems underpin these different symptoms (perhaps suggesting different treatment are appropriate for them)?

Are there particular genes that increase the risk of developing psychosis? If so, in what way do they increase the risk? Do they affect brain structure, thinking styles, memory? If we understand genes better it could help drug companies develop new drugs in future.  

Can we find blood tests that would help in diagnosing psychosis?, or blood tests to help predict which people with psychosis will tend to need more or less help from us?

Back to the top

TREATMENT RESEARCH 

Can medication improve the memory, concentration and problem solving difficulties? or does it only help with symptoms but not affect these issues?

Can talking therapy help people get back to work? 

Can talking therapy stop or delay mild psychosis worsening into severe illness?

Do specialist services like CAMEO produce better outcomes than traditional, non-specialist services?  

Is it helpful to spend money on paying for a specialist nurse to educate GPs and Colleges about psychosis? Would that help people with early psychosis get treatment and specialist help earlier? Or is it just as effective to send a leaflet to GPs and Colleges and use the money in other ways?

Who pays for the research we do?

The money comes from several sources. These include the Department of Health Research Budget (now called the National Institutes of Health Research), the Medical Research Council, The Stanley Medical Research Foundation (an American mental health research charity), Glaxo-Smith-Kline (a drugs company), NARSAD (another American mental health research charity). Often the money is awarded to us to do research in collaboration with Cambridge University. Another advantage of the research is that it sometimes means extra staff are available in CAMEO to do clinical work. We have several members of staff – doctors, nurses and social workers whose salary is paid from research funds but who also do part-time clinical work as well as research, and who have contracts with both the Trust and the University.  

The quality and ethical requirements of all the research we do is assured by external scientific reviews, the Cambridgeshire & Peterborough Foundation Trust that has clear clinical and research governance procedures and by NHS Research Ethics Committees. 

Back to the top

 

Terms Of Use  |  Privacy Statement
Copyrighted 2011 to CAMEO Early Intervention